Skip to main content

Javier Francisco Ramón Pasías

Institutions of which they are part

Postdoctoral researcher
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Javier Francisco Ramón Pasías

Institutions of which they are part

Postdoctoral researcher
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Projects

Identificación de factores reguladores de la función y estabilidad del complejo respiratorio mitocondrial I: explorando nuevas oportunidades terapéuticas (TARGETCOMPLEX-I)

IP: Yolanda Cámara Navarro
Collaborators: Elena García Arumí, Javier Francisco Ramón Pasías, Identificación de factores reguladores de la función y estabilidad del complejo respiratorio mitocondrial I: explorando nuevas , Izaskun Izagirre Urizar
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 275000
Reference: PID2023-147668OB-I00
Duration: 01/09/2024 - 31/12/2027

Ministerio de Ciencia

Models d'estudi de malalties degudes a manteniment defectuós del DNA mitocondrial

IP: Ramon Martí Seves
Collaborators: Mª Jesus Melia Grimal, Pau Mollá Zaragozá, Javier Francisco Ramón Pasías, Juan Luis Restrepo Vera
Funding agency: Instituto de Salud Carlos III
Funding: 208750
Reference: PI24/00838
Duration: 01/01/2025 - 31/12/2027

NUCLEOSIDES4MITO: Deoxynucleosides as a potential therapy for mitochondrial DNA maintenance disorders

IP: Ramon Martí Seves
Collaborators: Javier Francisco Ramón Pasías
Funding agency: Association Française contre les Myopathies (AFM)
Funding: 171100
Reference: NUCLEOSIDES4MITO_M.SEVES_AFM_2023
Duration: 01/01/2025 - 31/12/2026

Estudi de malalties neuromusculars i mitocondrials

IP: Ramon Martí Seves
Collaborators: Estudi de malalties neuromusculars i mitocondrials, Elena García Arumí, Yolanda Cámara Navarro, Mª Jesus Melia Grimal, Tomàs Pinós Figueras, Javier Francisco Ramón Pasías, Estudi de malalties neuromusculars i mitocondrials, Estudi de malalties neuromusculars i mitocondrials
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00894
Duration: 01/01/2022 - 30/06/2025

Related news

The projects, selected under the 2026 Health Research and CaixaImpulse Health Innovation calls, address topics ranging from new therapies for childhood neurological disorders and Parkinson’s disease to the treatment of mitochondrial diseases and cancer.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

Related professionals

Sergi Martí Beltran

Sergi Martí Beltran

Senior researcher
Pneumology
Read more
Maria Uriburu Gray

Maria Uriburu Gray

Gestió i Administració
Secretariat for Governance and Science Policy
Internal Strategy Directorate
Read more
Juan Cabezos Oton

Juan Cabezos Oton

Predoctoral researcher
Infectious Diseases
Read more
Galo David Granados Rosales

Galo David Granados Rosales

Predoctoral researcher
Pneumology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.